Logo image of EXK

ENDEAVOUR SILVER CORP (EXK) Stock Fundamental Analysis

USA - NYSE:EXK - CA29258Y1034 - Common Stock

7.26 USD
-0.24 (-3.2%)
Last: 11/5/2025, 8:04:00 PM
7.24 USD
-0.02 (-0.28%)
After Hours: 11/5/2025, 8:04:00 PM
Fundamental Rating

3

Overall EXK gets a fundamental rating of 3 out of 10. We evaluated EXK against 154 industry peers in the Metals & Mining industry. EXK has a bad profitability rating. Also its financial health evaluation is rather negative. EXK has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

EXK had negative earnings in the past year.
In the past year EXK had a positive cash flow from operations.
EXK had positive earnings in 4 of the past 5 years.
Each year in the past 5 years EXK had a positive operating cash flow.
EXK Yearly Net Income VS EBIT VS OCF VS FCFEXK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

EXK's Return On Assets of -6.99% is on the low side compared to the rest of the industry. EXK is outperformed by 64.29% of its industry peers.
With a Return On Equity value of -13.16%, EXK is not doing good in the industry: 64.94% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 0.28%, EXK is in line with its industry, outperforming 50.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for EXK is significantly below the industry average of 12.58%.
Industry RankSector Rank
ROA -6.99%
ROE -13.16%
ROIC 0.28%
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
EXK Yearly ROA, ROE, ROICEXK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

Looking at the Operating Margin, with a value of 1.11%, EXK is in line with its industry, outperforming 51.30% of the companies in the same industry.
In the last couple of years the Operating Margin of EXK has declined.
Looking at the Gross Margin, with a value of 16.47%, EXK is in line with its industry, outperforming 54.55% of the companies in the same industry.
EXK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.11%
PM (TTM) N/A
GM 16.47%
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
EXK Yearly Profit, Operating, Gross MarginsEXK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXK is destroying value.
The number of shares outstanding for EXK has been increased compared to 1 year ago.
Compared to 5 years ago, EXK has more shares outstanding
The debt/assets ratio for EXK is higher compared to a year ago.
EXK Yearly Shares OutstandingEXK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EXK Yearly Total Debt VS Total AssetsEXK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.44 indicates that EXK is not a great score, but indicates only limited risk for bankruptcy at the moment.
EXK has a Altman-Z score (2.44) which is comparable to the rest of the industry.
EXK has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
EXK has a Debt to Equity ratio (0.23) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 2.44
ROIC/WACC0.03
WACC8.32%
EXK Yearly LT Debt VS Equity VS FCFEXK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

EXK has a Current Ratio of 0.93. This is a bad value and indicates that EXK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of EXK (0.93) is worse than 85.71% of its industry peers.
A Quick Ratio of 0.65 indicates that EXK may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.65, EXK is doing worse than 82.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.65
EXK Yearly Current Assets VS Current LiabilitesEXK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

EXK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -600.00%.
The Revenue has grown by 11.64% in the past year. This is quite good.
The Revenue has been growing by 12.33% on average over the past years. This is quite good.
EPS 1Y (TTM)-600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)11.64%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%46.41%

3.2 Future

EXK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.69% yearly.
EXK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 33.18% yearly.
EPS Next Y144.19%
EPS Next 2Y188.31%
EPS Next 3Y96.22%
EPS Next 5Y53.69%
Revenue Next Year87.24%
Revenue Next 2Y75.52%
Revenue Next 3Y48.11%
Revenue Next 5Y33.18%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EXK Yearly Revenue VS EstimatesEXK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
EXK Yearly EPS VS EstimatesEXK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXK. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 14.38, the valuation of EXK can be described as correct.
61.04% of the companies in the same industry are more expensive than EXK, based on the Price/Forward Earnings ratio.
EXK is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 14.38
EXK Price Earnings VS Forward Price EarningsEXK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

EXK's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 56.34
EXK Per share dataEXK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

EXK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EXK's earnings are expected to grow with 96.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y188.31%
EPS Next 3Y96.22%

0

5. Dividend

5.1 Amount

EXK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENDEAVOUR SILVER CORP

NYSE:EXK (11/5/2025, 8:04:00 PM)

After market: 7.24 -0.02 (-0.28%)

7.26

-0.24 (-3.2%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-07 2025-11-07/bmo
Inst Owners50.49%
Inst Owner Change0.6%
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap2.11B
Revenue(TTM)247.75M
Net Income(TTM)-69637000
Analysts78.33
Price Target9.75 (34.3%)
Short Float %7.05%
Short Ratio1.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2921.78%
Min EPS beat(2)-5248.51%
Max EPS beat(2)-595.05%
EPS beat(4)1
Avg EPS beat(4)-1901.52%
Min EPS beat(4)-5248.51%
Max EPS beat(4)218.79%
EPS beat(8)2
Avg EPS beat(8)-1033.96%
EPS beat(12)2
Avg EPS beat(12)-718.86%
EPS beat(16)3
Avg EPS beat(16)-586.26%
Revenue beat(2)2
Avg Revenue beat(2)0.08%
Min Revenue beat(2)0.04%
Max Revenue beat(2)0.11%
Revenue beat(4)3
Avg Revenue beat(4)-2.5%
Min Revenue beat(4)-16.69%
Max Revenue beat(4)6.54%
Revenue beat(8)6
Avg Revenue beat(8)-0.8%
Revenue beat(12)8
Avg Revenue beat(12)-0.12%
Revenue beat(16)9
Avg Revenue beat(16)-2.55%
PT rev (1m)40.79%
PT rev (3m)48.1%
EPS NQ rev (1m)47.37%
EPS NQ rev (3m)75%
EPS NY rev (1m)0%
EPS NY rev (3m)-81.77%
Revenue NQ rev (1m)-2.82%
Revenue NQ rev (3m)18.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.38
P/S 8.5
P/FCF N/A
P/OCF 77.76
P/B 3.98
P/tB 3.98
EV/EBITDA 56.34
EPS(TTM)-0.21
EYN/A
EPS(NY)0.51
Fwd EY6.96%
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)0.09
OCFY1.29%
SpS0.85
BVpS1.82
TBVpS1.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.99%
ROE -13.16%
ROCE 0.35%
ROIC 0.28%
ROICexc 0.3%
ROICexgc 0.3%
OM 1.11%
PM (TTM) N/A
GM 16.47%
FCFM N/A
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
ROICexc(3y)3.56%
ROICexc(5y)N/A
ROICexgc(3y)3.56%
ROICexgc(5y)N/A
ROCE(3y)3.5%
ROCE(5y)N/A
ROICexgc growth 3Y-31.89%
ROICexgc growth 5YN/A
ROICexc growth 3Y-31.88%
ROICexc growth 5YN/A
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA 3.01
Cap/Depr 503.82%
Cap/Sales 76.86%
Interest Coverage 0.27
Cash Conversion 66.81%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.65
Altman-Z 2.44
F-Score3
WACC8.32%
ROIC/WACC0.03
Cap/Depr(3y)485.81%
Cap/Depr(5y)353.29%
Cap/Sales(3y)66.44%
Cap/Sales(5y)50.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y144.19%
EPS Next 2Y188.31%
EPS Next 3Y96.22%
EPS Next 5Y53.69%
Revenue 1Y (TTM)11.64%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%46.41%
Revenue Next Year87.24%
Revenue Next 2Y75.52%
Revenue Next 3Y48.11%
Revenue Next 5Y33.18%
EBIT growth 1Y100.07%
EBIT growth 3Y6.61%
EBIT growth 5YN/A
EBIT Next Year219.22%
EBIT Next 3Y109.71%
EBIT Next 5Y52.95%
FCF growth 1Y-134.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.85%
OCF growth 3Y-6.61%
OCF growth 5YN/A

ENDEAVOUR SILVER CORP / EXK FAQ

What is the ChartMill fundamental rating of ENDEAVOUR SILVER CORP (EXK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to EXK.


What is the valuation status for EXK stock?

ChartMill assigns a valuation rating of 4 / 10 to ENDEAVOUR SILVER CORP (EXK). This can be considered as Fairly Valued.


How profitable is ENDEAVOUR SILVER CORP (EXK) stock?

ENDEAVOUR SILVER CORP (EXK) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for EXK stock?

The Earnings per Share (EPS) of ENDEAVOUR SILVER CORP (EXK) is expected to grow by 144.19% in the next year.